AIMEE BRYANT: Open Payments
NPI 1518621887 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 18 payments from 7 companies in 2025. Trend: 2023 $210 · 2024 $259 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 4 | $88 |
| ABBVIE INC. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Janssen Scientific Affairs, LLC | 1 | $40 |
| GENZYME CORPORATION | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Phathom Pharmaceuticals, Inc. | 5 | $36 |
Products named: IBSRELA, DUPIXENT, CREON, TREMFYA, VOQUEZNA, EOHILIA, SKYRIZI, ENTYVIO.
Industry payments across KS — which companies pay providers there.
